Chemomab Therapeutics Ltd. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Tel Aviv
SEC filing record 1 source field available
Fiscal year end
31 December
Chemomab Therapeutics Ltd. has filed 362 SEC EDGAR filings since 07 Nov 2011

SEC filing history

Showing 226-250 of 362 matching filings.

Per page
25
Current page
10
EFFECT File 333-252070

EFFECT filing

Filing date
10 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
10 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
10 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-4/A File 333-252070

S-4/A

Filing date
10 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38807

FORM 8-K

Filing date
08 Feb 2021
Reporting date
08 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
425 File 001-38807

FORM 8-K

Filing date
08 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
425 File 001-38807

425

Filing date
02 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
15 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
425 File 001-38807

425

Filing date
11 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
425 File 001-38807

425

Filing date
05 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-86953

SC 13D/A

Filing date
21 Dec 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-86953

SC 13D/A

Filing date
18 Dec 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38807

FORM 8-K

Filing date
15 Dec 2020
Reporting date
14 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-38807

FORM 8-K

Filing date
15 Dec 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38807

FORM 8-K

Filing date
20 Oct 2020
Reporting date
20 Oct 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38807

FORM 8-K

Filing date
15 Jul 2020
Reporting date
15 Jul 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38807

FORM 8-K

Filing date
09 Jul 2020
Reporting date
09 Jul 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-86953

SC 13D/A

Filing date
22 May 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38807

FORM 8-K

Filing date
21 May 2020
Reporting date
21 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
07 May 2020
Reporting date
01 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38807

FORM 8-K

Filing date
06 May 2020
Reporting date
05 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .